Device Trial Radar · NCT01712191
Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant
Last checked: Nov 20, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
128
Actual
Start
Jan 2011
Primary completion
Dec 2013
Study completion Mar 2016
Sponsor
- Lead sponsor
- Phoenix KineticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 23, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 35 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center, open label, non-randomized study, evaluating the treating of medial meniscus deficiency with the NUsurface Meniscus Implant.
Conditions
- Meniscus; Degeneration
- Osteoarthritis, Knee
Interventions
NUsurface Meniscus ImplantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Knee injury and Osteoarthritis Outcome Score (KOOS)Time frame: 24 Months
Locations
10 sites in 6 countries. Site status is shown where the registry gives one.
AZ Monica
Antwerp, Belgium
Ghent University Hospital
Ghent, Belgium
Sporthopaedicum Berlin
Berlin, Germany
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.